Kintara Therapeutics
(NASDAQ:KTRA)
0.2915
0.0065[2.28%]
Last update: 2:57PM
15 minutes delayed
Day High/Low0.29 - 0.31
52 Week High/Low0.14 - 2.85
Open / Close0.31 / -
Float / Outstanding65.3M / 65.5M
Vol / Avg.2.1M / 4M
Mkt Cap19.1M
P/E-
50d Avg. Price0.22
Div / Yield-
Payout Ratio-
EPS-0.11
Total Float65.3M

Kintara Therapeutics (NASDAQ:KTRA), Quotes and News Summary

Kintara Therapeutics (NASDAQ: KTRA)

Day High/Low0.29 - 0.31
52 Week High/Low0.14 - 2.85
Open / Close0.31 / -
Float / Outstanding65.3M / 65.5M
Vol / Avg.2.1M / 4M
Mkt Cap19.1M
P/E-
50d Avg. Price0.22
Div / Yield-
Payout Ratio-
EPS-0.11
Total Float65.3M
Sector: Health Care.Industry: Biotechnology
Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and REM-001 for CMBC. VAL-083 is a small-molecule chemotherapeutic with a novel mechanism of action that has demonstrated clinical activity against a range of cancers, including central nervous system, ovarian, and other solid tumors. The company is also advancing its proprietary late stage photodynamic therapy (PDT) platform that holds promise as a localized cutaneous or visceral tumor treatment as well as in other potential indications.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2022-09-27
REV
Q3 2022Est.ActualSurprise
EPS-0.110
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Kintara Therapeutics Questions & Answers

Q
How do I buy Kintara Therapeutics (KTRA) stock?
A

You can purchase shares of Kintara Therapeutics (NASDAQ: KTRA) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Kintara Therapeutics's (KTRA) competitors?
Q
What is the target price for Kintara Therapeutics (KTRA) stock?
A

The latest price target for Kintara Therapeutics (NASDAQ: KTRA) was reported by Dawson James on Monday, May 16, 2022. The analyst firm set a price target for 0.00 expecting KTRA to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Kintara Therapeutics (KTRA)?
A

The stock price for Kintara Therapeutics (NASDAQ: KTRA) is $0.2915 last updated Today at June 27, 2022, 6:57 PM UTC.

Q
Does Kintara Therapeutics (KTRA) pay a dividend?
A

There are no upcoming dividends for Kintara Therapeutics.

Q
When is Kintara Therapeutics (NASDAQ:KTRA) reporting earnings?
A

Kintara Therapeutics’s Q4 earnings are confirmed for Tuesday, September 27, 2022.

Q
Is Kintara Therapeutics (KTRA) going to split?
A

There is no upcoming split for Kintara Therapeutics.

Q
What sector and industry does Kintara Therapeutics (KTRA) operate in?
A

Kintara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.